Bluebird Bio
ID: 5290462A company developing gene therapies for the treatment of genetic diseases and cancer.
6
Funding Rounds
$262.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ph****** Le****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Bluebird Bio has raised a total of $125m in funding over 6 rounds.
Key Insights:
- bluebird bio Series D round: $60m
- bluebird bio funding round, April 2011: $30m
- bluebird bio Series B round: $35m
- bluebird bio, Inc. funding round, July 2012: $60m
- Genetix Pharmaceuticals Inc funding round, March 2010: $47.41m
- bluebird bio, Inc. funding round, April 2011: $30m
Industries
Bluebird Bio is active in the following industries:
- Regenerative medicine
- Gene therapy
- CAR T-Cell therapy
- Biomedical engineering
- T cell
- Epigenetics
- Biology
- Biotechnology
- Healthcare
- Genomics
- Engineering
- Tissue engineering
- Immunotherapy
- Cell therapy
- Genome editing
- Drug discovery
- Genetic engineering
- Technology
- RNA-based and RNA-targeted therapeutics
- Rare disease